In 2018, the global hemophilia treatment market was valued at a whopping 11,474.3 million USD. Because of the rising occurrence of bleeding disorders like hemophilia, the overall market is expected to rise at a compound annual growth rate (CAGR), of 5.9%. That would bring the market size in 2027 to an massive 19.1 billion dollar industry. This is exciting for not only those who suffer from hemophilia, but also for major drug companies, which are expected to drive the bleeding disorder market through new strategies and products.
According to Centers for Disease Control and Prevention (CDC), 1 in 5,000 male births in the United States are affected with hemophilia. As of 2019 in 115 countries, about 195,263 people had hemophilia, (157,517 people with Hemophilia A), according to the World Federation of Hemophilia.
Comments